Madrigal Pharmaceuticals's chart data is dated 2026-10-08. There is no active technical signal. There are 7 published signal records.
Madrigal Pharmaceuticals last closed at $476.91 (-2.22%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -42.8×. Its overall grade ranks 484 of 738 stocks in Healthcare.
About this company
Madrigal Pharmaceuticals last closed at $476.91 (-2.22%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 484/738
Valuation grade C
Related stocks
- Novo NordiskCompetitor
MASH/NASH 치료제 개발 경쟁사
- Intercept PharmaceuticalsCompetitor
MASH/NASH 치료제 경쟁사
- Gilead SciencesCompetitor
MASH/NASH 및 간질환 치료제 개발 경쟁사
About Madrigal Pharmaceuticals
- What technical signals does Madrigal Pharmaceuticals (MDGL) have?
- Madrigal Pharmaceuticals current technical signals: no active technical signal.
- Is Madrigal Pharmaceuticals a cup-and-handle pattern?
- No. Madrigal Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Madrigal Pharmaceuticals?
- Market cap: $10.83B. Trailing 12 months PER: -42.8×. Latest quarter PBR: 26.54×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Madrigal Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.